Your browser does not seem to support JavaScript. As a result, your viewing experience will be diminished, and you have been placed in read-only mode.

Please download a browser that supports JavaScript, or enable it if it's disabled (i.e. NoScript).

J&J sees AI halving the time to generate drug development leads

General Medicine

1 Posts 1 Posters 3 Views

R This user is from outside of this forum
R This user is from outside of this forum
RAPPLER | Philippine & World News | Investigative Journalism | Data | Civic Engagement | Public Interest [Unofficial]

wrote last edited by

#1

Johnson & Johnson is using the new technology to screen the 'potential universe' for promising chemical compounds or biologics, CIO Jim Swanson says
1 Reply Last reply
1
0
T #medicine shared this topic

Hello! It looks like you're interested in this conversation, but you don't have an account yet.

Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

With your input, this post could be even better 💗